Cargando…

Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition

The non-genotoxic nature of proteasome inhibition makes it an attractive therapeutic option for the treatment of pediatric malignancies. We recently described the small molecule VLX1570 as an inhibitor of proteasome deubiquitinase (DUB) activity that induces proteotoxic stress and apoptosis in cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazurkiewicz, Magdalena, Hillert, Ellin-Kristina, Wang, Xin, Pellegrini, Paola, Olofsson, Maria Hägg, Selvaraju, Karthik, D’Arcy, Padraig, Linder, Stig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400570/ https://www.ncbi.nlm.nih.gov/pubmed/28423502 http://dx.doi.org/10.18632/oncotarget.15501

Ejemplares similares

The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
por: Wang, Xin, et al.
Publicado: (2016)

Corrigendum: The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
por: Wang, Xin, et al.
Publicado: (2016)

Proteasome-associated deubiquitinases and cancer
por: Mofers, Arjan, et al.
Publicado: (2017)

Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
por: Pellegrini, Paola, et al.
Publicado: (2020)

Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15
por: Mofers, Arjan, et al.
Publicado: (2019)

Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases
por: Sun, Chao, et al.
Publicado: (2014)

Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
por: Selvaraju, Karthik, et al.
Publicado: (2019)

Author Correction: Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
por: Selvaraju, Karthik, et al.
Publicado: (2019)

Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System
por: Selvaraju, Karthik, et al.
Publicado: (2021)

Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment
por: Zhang, Xiaonan, et al.
Publicado: (2019)

Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
por: Zhang, Xiaonan, et al.
Publicado: (2015)

MYC is downregulated by a mitochondrial checkpoint mechanism
por: Zhang, Xiaonan, et al.
Publicado: (2017)

Comprehensive Target Screening and Cellular Profiling of the Cancer-Active Compound b-AP15 Indicate Abrogation of Protein Homeostasis and Organelle Dysfunction as the Primary Mechanism of Action
por: Gubat, Johannes, et al.
Publicado: (2022)

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
por: Corno, Cristina, et al.
Publicado: (2022)

A drug screening assay on cancer cells chronically adapted to acidosis
por: Pellegrini, Paola, et al.
Publicado: (2018)

Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
por: Sarhan, Dhifaf, et al.
Publicado: (2014)

Deubiquitinase Ubp3 enhances the proteasomal degradation of key enzymes in sterol homeostasis
por: Lan, Qiuyan, et al.
Publicado: (2021)

Iron chelators target both proliferating and quiescent cancer cells
por: Fryknäs, Mårten, et al.
Publicado: (2016)

Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases
por: Moon, Seonghyeon, et al.
Publicado: (2021)

Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds
por: Liu, Ningning, et al.
Publicado: (2015)

Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
por: Chen, Xin, et al.
Publicado: (2017)

Atomic structure of the 26S proteasome lid reveals the mechanism of deubiquitinase inhibition
por: Dambacher, Corey M, et al.
Publicado: (2016)

Ubp6 deubiquitinase controls conformational dynamics and substrate degradation of the 26S proteasome
por: Bashore, Charlene, et al.
Publicado: (2015)

Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2019)

Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II
por: Olofsson, Maria Hägg, et al.
Publicado: (2008)

Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters
por: Fayad, Walid, et al.
Publicado: (2009)

Deubiquitinase activity is required for the proteasomal degradation of misfolded cytosolic proteins upon heat-stress
por: Fang, Nancy N., et al.
Publicado: (2016)

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
por: Vdovin, Alexander, et al.
Publicado: (2022)

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
por: Liu, Ningning, et al.
Publicado: (2014)

Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments
por: Zhang, Xiaonan, et al.
Publicado: (2014)

Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers
por: Zhang, Xiaonan, et al.
Publicado: (2020)

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
por: Liu, Ningning, et al.
Publicado: (2014)

Spatial Organization of Proteasome Aggregates in the Regulation of Proteasome Homeostasis
por: Karmon, Ofri, et al.
Publicado: (2020)

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
por: Clemente, Valentino, et al.
Publicado: (2020)

Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer
por: Xia, Xiaohong, et al.
Publicado: (2018)

Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasome
por: Lee, Yun-Tzai Cloud, et al.
Publicado: (2017)

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
por: Rowinsky, Eric K., et al.
Publicado: (2020)

Deubiquitinases in cancer
por: Wei, Rongbin, et al.
Publicado: (2015)

Deubiquitinases in Neurodegeneration
por: Bello, Abudu I., et al.
Publicado: (2022)

Ubiquitin-Specific Peptidase 7: A Novel Deubiquitinase That Regulates Protein Homeostasis and Cancers
por: Zhou, Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7aa2j3sjbdtvh4vjtgj3ke89k